Clinical Trial of Imatinib with or without Hydroxyurea in patients of Leukaemia
Phase 2
- Conditions
- Health Condition 1: C921- Chronic myeloid leukemia, BCR/ABL-positive
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed patients of chronic phase chronic myeloid leukemia, age >= 18 years & of either sex, who are willing to provide consent.
Exclusion Criteria
1.Patients with de novo accelerated phase or blast phase CML.
2.Patients who have already started either hydroxyurea or any tyrosine kinase inhibitor (TKI) treatment prior to randomization.
3.Pregnancy.
4.CML patients with active second malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method